REVDOFILIMAB

UNII: 2Y83Y2ORD3
Preferred Substance Name: REVDOFILIMAB

2230138-89-1
ABBV368
ABBV-368
ABBV-368 (HUMANIZED, RECOMBINANT MONOCLONAL ANTIBODY THAT BINDS TO CELL SURFACE EXPRESSED OX40 (TNF RECEPTOR SUPERFAMILY MEMBER 4))
ANTI-OX40 AGONIST MONOCLONAL ANTIBODY ABBV-368
MAB HUMANIZED (IGG1) ANTI P43489 (TNR4_HUMAN) (ABBV368)
PR1628103
PR-1628103
REVDOFILIMAB [INN]
REVDOFILIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

REVDOFILIMAB

Synonyms and Mappings

Resources

Note